Statistics
The ARS Pharmaceuticals stock price is currently $ 3.89 with a total market cap valuation of $ 391.05M (100.53M shares outstanding). The ARS Pharmaceuticals is trading on NASDAQ under the ticker sign SPRY. ARS Pharmaceuticals price is up
Description
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
Company Profile
- Full Name: ARS Pharmaceuticals
- Sector: Healthcare
- Website: https://ars-pharma.com
